Durvalumab versus Physician’s Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-07-24
DOI
https://doi.org/10.1158/1078-0432.ccr-25-0201
Citations
8
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
13.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Durvalumab versus Physician’s Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial

Samuel G.W. Ow, Diana Lim, Tuan Zea Tan, Junxian Zhu et al.
8 citations
Clinical Cancer Research
Ovarian cancer diagnosis and treatment
13.58
article

Durvalumab versus Physician’s Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial

Samuel G.W. Ow, Diana Lim, Tuan Zea Tan, Junxian Zhu, Michael Leonard Friedlander, Haoyang Sun, Natalie Y.L. Ngoi, Hee Seung Kim, Jae‐Weon Kim, Kidong Kim, David S.P. Tan, Wen Yee Chay, Chel Hun Choi, Geraldine Goss, Siew Eng Lim, Valerie Heong, Bee Choo Tai, Jeffrey C. Goh, Yi Wan Lim
article en
8 citations

Abstract

No abstract available for this paper.
Clinical Cancer ResearchVol. 31(18)
Box Hill Hospital (AU), Seoul National University (KR), National University of Singapore (SG), Royal Brisbane and Women's Hospital (AU), Samsung Medical Center (KR), Tan Tock Seng Hospital (SG), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), UNSW Sydney (AU), National University Cancer Institute, Singapore (SG), Prince of Wales Hospital (AU), National Cancer Centre Singapore (SG), National University Hospital (SG), National University Health System (SG), Bristol-Myers Squibb (South Korea) (KR)
AstraZeneca, Medical Research Council, National Medical Research Council
Good health and well-being
Openalex Percentile: Top 1%
Ovarian cancer diagnosis and treatment
13.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.